We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter Genomics Offers Sequencing Services

By LabMedica International staff writers
Posted on 14 Aug 2009
Beckman Coulter (Fullerton, CA, USA) has formed Beckman Coulter Genomics (Beverly, MA, USA), combining the operations of its Agencourt Bioscience business with Cogenics, a firm it recently purchased.

Beckman Coulter Genomics will offer scientists genomic service resources with expanded global capabilities. It will provide a variety of services including sequencing, sample preparation, genotyping, gene expression, biologic efficiency and safety testing, as well as support for regulatory compliance including Clinical Laboratory Improvement Amendments (CLIA). In addition, it will offer nucleic acid purification products, thus serving both the life-science and pharmaceutical industries.

Richard Creager, Beckman Coulter group vice president of immunoassay, molecular diagnostics, and genomic services, stated, "Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry's leading genomic service providers to offer our customers the highest-quality data and analysis."

Beckman Coulter, Inc., develops, manufactures, and markets products that simplify, automate, and develop complex biomedical tests.

Related Links:
Beckman Coulter
Beckman Coulter Genomics
Agencourt Bioscience
Cogenics


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
All-in-One Molecular System
AIO M160

Latest Industry News

Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio
14 Aug 2009  |   Industry

Agilent Strengthens Pathology Capabilities Through Biocare Acquisition
14 Aug 2009  |   Industry

Project Aims to Develop First Single-Cell Assay for ADC Therapies
14 Aug 2009  |   Industry



ADLM